Literature DB >> 7008252

Lack of expression of HLA antigens on choriocarcinoma cell lines.

E A Jones, W F Bodmer.   

Abstract

A panel of monoclonal antibodies against HLA--A, B, C, DRw, beta 2 m and other determinants on human cells has been used in indirect trace binding and absorption assays to determine the distribution of these antigens on choriocarcinoma cell lines. HLA--A, B, C, DRw and beta 2 m were not found on these cell lines, while other human antigens expressed on most human tissues were expressed on all the lines.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7008252     DOI： 10.1111/j.1399-0039.1980.tb00603.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN： 0001-2815


  9 in total

1.  Developmental and tissue-specific expression of the Q5k gene.

Authors:  S Schwemmle; D Bevec; G Brem; M B Urban; P A Baeuerle; E H Weiss
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  K562 cells express human major histocompatibility antigens.

Authors:  A Ziegler; D Laudien; H Heinrichs; C Müller; B Uchańska-Ziegler; P Wernet
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

Review 3.  Experimental strategies for modification of histocompatibility antigens in tumor cells.

Authors:  J Vogel; K Tanaka; G S Hoekzema; G Jay
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Altered growth of a human neuroendocrine carcinoma line after transfection of a major histocompatibility complex class I gene.

Authors:  M E Sunday; K J Isselbacher; S Gattoni-Celli; C G Willett
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  Increased projection of MHC and tumor antigens in murine B16-BL6 melanoma induced by hydrostatic pressure and chemical crosslinking.

Authors:  V Ramakrishna; A Eisenthal; Y Skornick; M Shinitzky
Journal:  Cancer Immunol Immunother       Date:  1993-05       Impact factor: 6.968

6.  Expression of major histocompatibility complex class I antigens as a strategy for the potentiation of immune recognition of tumor cells.

Authors:  K Tanaka; H Hayashi; C Hamada; G Khoury; G Jay
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

7.  An immunohistological study of HLA antigen expression by gestational choriocarcinoma.

Authors:  C A Sunderland; M Sasagawa; K Kanazawa; G M Stirrat; S Takeuchi
Journal:  Br J Cancer       Date:  1985-06       Impact factor: 7.640

8.  Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes.

Authors:  F Plata; A F Tilkin; J P Lévy; F Lilly
Journal:  J Exp Med       Date:  1981-12-01       Impact factor: 14.307

9.  Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection.

Authors:  J S Weber; G Jay; K Tanaka; S A Rosenberg
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.